Page last updated: 2024-08-21

imperatorin and Atherogenesis

imperatorin has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, Q; Li, W; Niu, X; Xiao, X; Yang, Y; Yu, J; Zang, L	1

Other Studies

1 other study(ies) available for imperatorin and Atherogenesis

Article	Year
Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro. International immunopharmacology, 2021, Volume: 90 Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cytokines; Furocoumarins; Inflammation; Lipid Metabolism; Lipids; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal	2021

Article

Year

Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro.

International immunopharmacology, 2021, Volume: 90

Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cytokines; Furocoumarins; Inflammation; Lipid Metabolism; Lipids; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal

2021